Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
European Commission
Pharma
EU signs off on Regeneron's T-cell engager for 2 blood cancers
Five months after the FDA rejected Regeneron’s bid for approval of odronextamab, the European Union has signed off on the treatment.
Kevin Dunleavy
Aug 26, 2024 10:35am
CSL Vifor promises marketing campaign to resolve EU probe
Jul 22, 2024 11:18am
J&J's tuberculosis med Sirturo nabs full FDA, EU nods
Jul 8, 2024 11:10am
CHMP rejects Apellis' Syfovre, says yes to Merck's Winrevair
Jun 28, 2024 11:59am
Regulatory tracker: CSL's gene therapy secures new coverage
Jun 28, 2024 9:30am
API manufacturer Alchem accused by EC in price-fixing scheme
Jun 13, 2024 10:45am
